Literature DB >> 7636989

A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients.

S Günther1, B C Li, S Miska, D H Krüger, H Meisel, H Will.   

Abstract

Current knowledge of hepatitis B virus (HBV) sequence heterogeneity is based mainly on sequencing of amplified subgenomic HBV fragments. Here, we describe a method which allows sensitive amplification and simplified functional analysis of full-length HBV genomes with or without prior cloning. By this method, a large number of HBV genomes were cloned from sera of six immunosuppressed kidney transplant patients. Two size classes of HBV genomes, one 3.2 kb and another about 2.0 kb in size, were found in all patients. The genome population from one serum sample was studied in detail by size analysis of subgenomic PCR fragments and sequencing. Regions with deletions and insertions were mapped in the C gene and pre-S region. Up to 100% of HBV genomes in all other immunosuppressed patients also had deletions in the C gene. Our results demonstrate the potential of the established method for the structural and functional characterization of heterogeneous populations of complete virion-encapsidated HBV DNAs and suggest that HBV genomes with C gene deletions can have a selective advantage in immunosuppressed patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7636989      PMCID: PMC189390     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  A new hepatitis B virus variant in a chronic carrier with multiple episodes of viral reactivation and acute hepatitis.

Authors:  G Raimondo; R Schneider; M Stemler; V Smedile; G Rodino; H Will
Journal:  Virology       Date:  1990-11       Impact factor: 3.616

Review 2.  Clinical implications of hepatitis B virus envelope protein variation.

Authors:  L A Wallace; W F Carman
Journal:  Int J Clin Lab Res       Date:  1994

3.  Identification of a doubly spliced viral transcript joining the separated domains for putative protease and reverse transcriptase of hepatitis B virus.

Authors:  P J Chen; C R Chen; J L Sung; D S Chen
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

4.  In vitro replication competence of a cloned hepatitis B virus variant with a nonsense mutation in the distal pre-C region.

Authors:  S P Tong; C Diot; P Gripon; J Li; L Vitvitski; C Trépo; C Guguen-Guillouzo
Journal:  Virology       Date:  1991-04       Impact factor: 3.616

5.  Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication.

Authors:  H E Blum; E Galun; T J Liang; F von Weizsäcker; J R Wands
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

6.  Characterization and genetic analysis of alternatively spliced transcripts of hepatitis B virus in infected human liver tissues and transfected HepG2 cells.

Authors:  H L Wu; P J Chen; S J Tu; M H Lin; M Y Lai; D S Chen
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

7.  A precore-defective mutant of hepatitis B virus associated with e antigen-negative chronic liver disease.

Authors:  P P Ulrich; R A Bhat; I Kelly; M R Brunetto; F Bonino; G N Vyas
Journal:  J Med Virol       Date:  1990-10       Impact factor: 2.327

8.  Prevalence and type of pre-C HBV mutants in anti-HBe positive carriers with chronic liver disease in a highly endemic area.

Authors:  T Santantonio; M C Jung; S Miska; G Pastore; G R Pape; H Will
Journal:  Virology       Date:  1991-08       Impact factor: 3.616

9.  Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli.

Authors:  F Galibert; E Mandart; F Fitoussi; P Tiollais; P Charnay
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

10.  Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen.

Authors:  H Okamoto; S Yotsumoto; Y Akahane; T Yamanaka; Y Miyazaki; Y Sugai; F Tsuda; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

View more
  164 in total

1.  Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative disease.

Authors:  Christopher P Desmond; Silvana Gaudieri; Ian R James; Katja Pfafferott; Abha Chopra; George K Lau; Jennifer Audsley; Caroline Day; Sarah Chivers; Adam Gordon; Peter A Revill; Scott Bowden; Anna Ayres; Paul V Desmond; Alexander J Thompson; Stuart K Roberts; Stephen A Locarnini; Simon A Mallal; Sharon R Lewin
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome.

Authors:  Laura Belloni; Lena Allweiss; Francesca Guerrieri; Natalia Pediconi; Tassilo Volz; Teresa Pollicino; Joerg Petersen; Giovanni Raimondo; Maura Dandri; Massimo Levrero
Journal:  J Clin Invest       Date:  2012-01-17       Impact factor: 14.808

3.  Improved method for rapid and efficient determination of genome replication and protein expression of clinical hepatitis B virus isolates.

Authors:  Yanli Qin; Jiming Zhang; Tamako Garcia; Kiyoaki Ito; Danielle Gutelius; Jisu Li; Jack Wands; Shuping Tong
Journal:  J Clin Microbiol       Date:  2011-02-02       Impact factor: 5.948

4.  New complex recombinant genotype of hepatitis B virus identified in Vietnam.

Authors:  Thien Tuan Huy Tran; Thi Ngoc Trinh; Kenji Abe
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

5.  Coexistence of hepatitis B virus quasispecies enhances viral replication and the ability to induce host antibody and cellular immune responses.

Authors:  Liang Cao; Chunchen Wu; Hui Shi; Zuojiong Gong; Ejuan Zhang; Hui Wang; Kaitao Zhao; Shuhui Liu; Songxia Li; Xiuzhu Gao; Yun Wang; Rongjuan Pei; Mengji Lu; Xinwen Chen
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

6.  Novel nucleoside analogue MCC-478 (LY582563) is effective against wild-type or lamivudine-resistant hepatitis B virus.

Authors:  Suzane Kioko Ono-Nita; Naoya Kato; Yasushi Shiratori; Flair José Carrilho; Masao Omata
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

7.  Full-length hepatitis B virus sequences from naïve patients with fluctuation of viral load during ADV monotherapy.

Authors:  Yongwei Li; Mingfen Zhu; Yunwei Guo; Wei Chen; Gang Li
Journal:  Virus Genes       Date:  2009-12-12       Impact factor: 2.332

8.  Replication of clinical hepatitis B virus isolate and its application for selecting antiviral agents for chronic hepatitis B patients.

Authors:  Yin-Ping Lu; Tao Guo; Bao-Ju Wang; Ji-Hua Dong; Jian-Fang Zhu; Zhao Liu; Meng-Ji Lu; Dong-Liang Yang
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

9.  Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice.

Authors:  Zhihua Qi; Gaiyun Li; Hao Hu; Chunhui Yang; Xiaoming Zhang; Qibin Leng; Youhua Xie; Demin Yu; Xinxin Zhang; Yueqiu Gao; Ke Lan; Qiang Deng
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

10.  Identification and characterization of genotype A and D recombinant hepatitis B virus from Indian chronic HBV isolates.

Authors:  Ranjit Chauhan; Syed-Naqui Kazim; Manoj Kumar; Jayashree Bhattacharjee; Narayanasamy Krishnamoorthy; Shiv-Kumar Sarin
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.